In Focus

  • 27 May 2020 - 33,000 viral genomic sequences of hCoV-19 shared via GISAID with unprecedented speed

    33,000 viral genomic sequences of hCoV-19 shared with unprecedented speed via GISAID

    Since the start of the COVID-19 outbreak and the identification of the pandemic virus, laboratories around the world are generating viral genome sequence data with unprecedented speed, enabling real-time progress in the understanding of the new disease and in the research and development of candidate medical countermeasures. Sequence data are essential to design and evaluate diagnostic tests, to track and trace the ongoing outbreak, and to identify potential intervention options. Listen to PRI's Elana Gordon.

    GISAID data Submitters and Curators ensure real-time data sharing of hCoV-19 remains reliable, to enable rapid progress in the understanding of the new COVID-19 disease and in the research and development of candidate medical countermeasures.

  • 13 April 2020 - Discussion on different types or clades of the virus and their origin

    GISAID Comments on the Discussion of Different Types or Clades of the hCoV-19 Virus and their Origin

    As the outbreak evolves over time and more data becomes available, several colleagues have analyzed and proposed different "types" of the virus and their origin.

    It is important to note that there is currently not enough data from the early outbreak period to interpret the early history of global transmissions from few genomes in detail. Links that seem directly connected now are likely to be connected via other cases also from other countries not sampled and sometimes can be connected differently later with more data.                              

    > read GISAID's Comments

  • CBD Study finds GISAID might provide useful lessons and insight to ABS discussion

    CBD Study finds 'GISAID might provide useful lessons and insight to ABS discussions'

    A peer-reviewed fact-finding and scoping study on digital sequence information on genetic resources in the context of the Convention on Biological Diversity and the Nagoya Protocol, highlights key advantages of GISAID’s sharing mechanism and a fair and equitable benefit-sharing resulting from access to data.

    With the core principals of timely international sharing of health data for protecting populations against lethal infectious disease outbreaks and adherence to scientific etiquette of acknowledgement of the source of data has resulted in global trust and confidence in GISAID. 

    > download the fact-finding & scoping study

  • 19 May 2017 G20 Health Ministers

    G20 Health Ministers recognize the importance of GISAID in regard to virus data sharing

    At the invitation of Germany, the first meeting of Health Ministers of the Group of Twenty leading industrialized and emerging economies (G20) took place in Berlin between 19-20 May 2017.

    Under the banner of “Together Today for a Healthy Tomorrow – Joint Commitment for Shaping Global Health”, the two-day meeting focused on combating global health hazards. In their Berlin Declaration, the G20 Health Ministers recognize the importance of the Global Initiative on Sharing All Influenza Data (GISAID).

    > read more
    > The Berlin Declaration of the G20 Health Ministers (2017)

Shirleen Soh
Genome Institute of Singapore A*STAR

Christophe Malabat
CNRS & Institut Pasteur, Paris

Aengus Stewart
The Francis Crick Institute, London

Sheila Ons
Universidad Nacional de La Plata, Buenos Aires

Thomas Bigot
CNRS & Institut Pasteur, Paris

Daniel See Rui En
Bioinformatics Institute Singapore A*Star

Deborah Schneider-Luftman
The Francis Crick Institute, London

Kirsten Roomp
Luxembourg Centre for Systems Biomedicine

Paola Cristina Resende Silva
Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro

Pablo Soro Barrio
The Francis Crick Institute, London

Natalia Pietrosemoli
CNRS & Institut Pasteur, Paris

Suma Tiruvayipati
Genome Institute of Singapore A*Star

Marcos Sterkel
Universidad Nacional de La Plata, Buenos Aires

Richard Mitter
The Francis Crick Institute, London

Mariana Viegas
National Council of Scientific & Technical Research, Buenos Aires

Claudia Chica
CNRS & Institut Pasteur, Paris

Kathryn A. Jackson-Jones
University of Edinburgh, MRC Human Genetics Unit

Amandine Perrin
CNRS & Institut Pasteur, Paris

Raphael Lee Tze Chuen
Bioinformatics Institute Singapore A*Star

Jose Manuel Latorre
National Council of Scientific & Technical Research, Buenos Aires

Hervé Ménager
CNRS & Institut Pasteur, Paris

Stephanie Goya
Hospital de Niños Dr. Ricardo Gutiérrez, Buenos Aires

Gael Millot
CNRS & Institut Pasteur, Paris

Gavin Kelly
The Francis Crick Institute, London

Gabriel Lihue Rojo
Hospital de Niños Dr. Ricardo Gutierrez, Buenos Aires

Olov Svartström
Public Health Agency of Sweden

Emmanuelle Permal
Pasteur Institute, Paris

Fernanda Sirota
Bioinformatics Institute Singapore A*Star

Emna Achouri
CNRS & Institut Pasteur, Paris

Lucila Traverso
National Council of Scientific & Technical Research, Buenos Aires

Damien Mornico
CNRS & Institut Pasteur, Paris

Corinne Maufrais
CNRS & Institut Pasteur, Paris

Probir Chakravarty
The Francis Crick Institute, London

Xiaofeng Wei
CNGb Beijing Genomics Institute, Shenzhen

Amine Ghozlane
CNRS & Institut Pasteur, Paris

Yu Xing Teo
Bioinformatics Institute Singapore A*Star

Sarasvathi Easwvaran
Adelaide, Australia

Quentin Giai Gianetto
CNRS & Institut Pasteur, Paris

Lina Wang
CNGb Beijing Genomics Institute, Shenzhen

Amaury Vaysse
CNRS & Institut Pasteur, Paris

Shirleen Soh
Genome Institute of Singapore A*STAR

Christophe Malabat
CNRS & Institut Pasteur, Paris

Aengus Stewart
The Francis Crick Institute, London

Sheila Ons
Universidad Nacional de La Plata, Buenos Aires

Thomas Bigot
CNRS & Institut Pasteur, Paris

Daniel See Rui En
Bioinformatics Institute Singapore A*Star

Deborah Schneider-Luftman
The Francis Crick Institute, London

Kirsten Roomp
Luxembourg Centre for Systems Biomedicine

Paola Cristina Resende Silva
Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro

Pablo Soro Barrio
The Francis Crick Institute, London

Natalia Pietrosemoli
CNRS & Institut Pasteur, Paris

Suma Tiruvayipati
Genome Institute of Singapore A*Star

Marcos Sterkel
Universidad Nacional de La Plata, Buenos Aires

Richard Mitter
The Francis Crick Institute, London

Mariana Viegas
National Council of Scientific & Technical Research, Buenos Aires

Claudia Chica
CNRS & Institut Pasteur, Paris

Kathryn A. Jackson-Jones
University of Edinburgh, MRC Human Genetics Unit

Amandine Perrin
CNRS & Institut Pasteur, Paris

Raphael Lee Tze Chuen
Bioinformatics Institute Singapore A*Star

Jose Manuel Latorre
National Council of Scientific & Technical Research, Buenos Aires

Hervé Ménager
CNRS & Institut Pasteur, Paris

Stephanie Goya
Hospital de Niños Dr. Ricardo Gutiérrez, Buenos Aires

Gael Millot
CNRS & Institut Pasteur, Paris

Xingyu Zhu
Bioinformatics Institute Singapore A*Star

Gavin Kelly
The Francis Crick Institute, London

Gabriel Lihue Rojo
Hospital de Niños Dr. Ricardo Gutierrez, Buenos Aires

Olov Svartström
Public Health Agency of Sweden

Emmanuelle Permal
Pasteur Institute, Paris

Fernanda Sirota
Bioinformatics Institute Singapore A*Star

Emna Achouri
CNRS & Institut Pasteur, Paris

Lucila Traverso
National Council of Scientific & Technical Research, Buenos Aires

Damien Mornico
CNRS & Institut Pasteur, Paris

Corinne Maufrais
CNRS & Institut Pasteur, Paris

Probir Chakravarty
The Francis Crick Institute, London

Xiaofeng Wei
CNGb Beijing Genomics Institute, Shenzhen

Amine Ghozlane
CNRS & Institut Pasteur, Paris

Sarasvathi Easwvaran
Adelaide, Australia

Quentin Giai Gianetto
CNRS & Institut Pasteur, Paris

Lina Wang
CNGb Beijing Genomics Institute, Shenzhen

Amaury Vaysse
CNRS & Institut Pasteur, Paris

Public-Private Partnerships of the GISAID Initiative

The GISAID Initiative, originally known as a Global Initiative on Sharing All Influenza Data, involves public-private-partnerships between the Initiative's administrative arm Freunde of GISAID e.V., a registered non-profit association, and governments of the Federal Republic of Germany, the official host of the GISAID platform, Singapore and the United States of America, with support from private and corporate philanthropy.